SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-056434
Filing Date
2023-10-30
Accepted
2023-10-30 17:00:03
Documents
7
Period of Report
2023-10-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A sabs_def14a_pipe_2023_sp.htm DEF 14A 320497
2 GRAPHIC img5587186_0.jpg GRAPHIC 12897
3 GRAPHIC img5587186_1.jpg GRAPHIC 5049
4 GRAPHIC img5587186_2.jpg GRAPHIC 6824
5 GRAPHIC img5587186_3.jpg GRAPHIC 5183
6 GRAPHIC img5587186_4.jpg GRAPHIC 516745
7 GRAPHIC img5587186_5.jpg GRAPHIC 173508
  Complete submission text file 0000950170-23-056434.txt   1313750
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39871 | Film No.: 231361152
SIC: 2836 Biological Products, (No Diagnostic Substances)